PL394981A1 - Granulat metanosulfonianu imatinibu, sposób jego wytwarzania i zastosowanie do wytwarzania stalych doustnych preparatów farmaceutycznych - Google Patents

Granulat metanosulfonianu imatinibu, sposób jego wytwarzania i zastosowanie do wytwarzania stalych doustnych preparatów farmaceutycznych

Info

Publication number
PL394981A1
PL394981A1 PL394981A PL39498111A PL394981A1 PL 394981 A1 PL394981 A1 PL 394981A1 PL 394981 A PL394981 A PL 394981A PL 39498111 A PL39498111 A PL 39498111A PL 394981 A1 PL394981 A1 PL 394981A1
Authority
PL
Poland
Prior art keywords
preparation
pharmaceutical preparations
solid oral
oral pharmaceutical
imatinib mesylate
Prior art date
Application number
PL394981A
Other languages
English (en)
Other versions
PL223392B1 (pl
Inventor
Arkadiusz Hejduk
Katarzyna Wierzchucka
Original Assignee
Vipharm Spólka Akcyjna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vipharm Spólka Akcyjna filed Critical Vipharm Spólka Akcyjna
Priority to PL394981A priority Critical patent/PL223392B1/pl
Publication of PL394981A1 publication Critical patent/PL394981A1/pl
Publication of PL223392B1 publication Critical patent/PL223392B1/pl

Links

PL394981A 2011-05-23 2011-05-23 Sposób wytwarzania granulatu zawierającego metanosulfonian imatinibu w odmianie krystalicznej α jako jedyny składnik PL223392B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL394981A PL223392B1 (pl) 2011-05-23 2011-05-23 Sposób wytwarzania granulatu zawierającego metanosulfonian imatinibu w odmianie krystalicznej α jako jedyny składnik

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL394981A PL223392B1 (pl) 2011-05-23 2011-05-23 Sposób wytwarzania granulatu zawierającego metanosulfonian imatinibu w odmianie krystalicznej α jako jedyny składnik

Publications (2)

Publication Number Publication Date
PL394981A1 true PL394981A1 (pl) 2012-12-03
PL223392B1 PL223392B1 (pl) 2016-10-31

Family

ID=47264148

Family Applications (1)

Application Number Title Priority Date Filing Date
PL394981A PL223392B1 (pl) 2011-05-23 2011-05-23 Sposób wytwarzania granulatu zawierającego metanosulfonian imatinibu w odmianie krystalicznej α jako jedyny składnik

Country Status (1)

Country Link
PL (1) PL223392B1 (pl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3257499A1 (en) 2016-06-17 2017-12-20 Vipharm S.A. Process for preparation of imatinib methanesulfonate capsules

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3257499A1 (en) 2016-06-17 2017-12-20 Vipharm S.A. Process for preparation of imatinib methanesulfonate capsules

Also Published As

Publication number Publication date
PL223392B1 (pl) 2016-10-31

Similar Documents

Publication Publication Date Title
HRP20181364T1 (hr) Aminotriazolopiridin, namijenjen upotrebi u liječenju upale, te njegovi farmacetski pripravci
IL231536A (en) Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases
BR112014021103A8 (pt) anticorpo, composição farmacêutica, droga de combinação, dna, método de tratamento e uso de anticorpo
HK1199712A1 (en) 18-methyl-6,7-methylene-3-oxo-17-pregn-4-ene-21,17-carbolactones, pharmaceutical preparations comprising said compounds and use thereof in the treatment of endometriosis 18--67--3--17--4--2117-
IL221160A (en) 4,2,1-triazine-3-amine derivatives, a process for their preparation and use for drug preparation
BR112015003376A2 (pt) composto ou sal farmaceuticamente aceitável do mesmo , composição farmacêutica e usos de quantidade eficiente
HK1202415A1 (en) Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15- hetre and methods of use thereof dgla15-ohepa/ 15-hetre
CL2014003232A1 (es) Formulaciones y métodos para la administración vaginal de antiprogestinas.
BR112014009634A2 (pt) preparação e agente terapêutico
BR112012022879A2 (pt) composto, composição farmacêutica, uso do composto e método de tratamento
BR112014012005A2 (pt) composições, métodos, formulação farmacêutica e artigo
BR112012022878A2 (pt) composto, composição farmacêutica, uso do compostos e método de tratamento
EP2726066A4 (en) DOSAGE FORMS FOR ORAL ADMINISTRATION AND METHODS OF TREATMENT USING THE SAME
IL233757A0 (en) Anti '1m e-gi antibodies and methods of using them
HK1199401A1 (en) Pharmaceutical formulations and the use thereof for the treatment of peanut allergy
BR112014010290A2 (pt) composição farmacêutica, métodos, composições e usos
PL2655375T3 (pl) Pochodne pirymidynonu, ich wytwarzanie i ich farmaceutyczne zastosowanie
EP2578596A4 (en) LEVOCARRIMYCIN, ITS PHARMACEUTICAL COMPOSITIONS, PREPARATION METHODS AND USES THEREOF
CO6970609A2 (es) Composición farmacéutica y métodos de uso de derivados de 4-pregenen-11ß-17-21-triol-3,20-diona
ITTO20110641A1 (it) Composizioni farmaceutiche e metodi di trattamento
EP2786982A4 (en) AMINO-PROPYLENE-GLYCOL DERIVATIVES, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF
BRPI0915527A2 (pt) pepitídeos, composição farmacêutica e exossomos compreendendo os mesmos, métodos e usos
BR112014000773A2 (pt) composições de nicotinamida e uso terapêutico das mesmas
BR112013017267A2 (pt) formulação de lipossomas, suspensão e composição farmacêutica
SG10201604468QA (en) Shk-based pharmaceutical compositions and methods of manufacturing and using the same